The rapid evolution of next-generation sequencing (NGS) technologies is transforming genomics research, precision medicine, and molecular diagnostics. While sequencing platforms continue to become faster and more affordable, sample preparation remains one of the most critical steps in generating accurate and reliable sequencing data. As laboratories increasingly adopt high-throughput sequencing workflows, demand for advanced NGS sample preparation solutions continues to rise.

According to recent market analysis, the global NGS Sample Preparation Market is projected to grow from USD 1.9 billion in 2022 to USD 4.0 billion by 2028, expanding at a CAGR of 13.4% during the forecast period.

Growing investments in genomics research, declining sequencing costs, advancements in sequencing technologies, and expanding clinical applications are fueling strong market growth across research institutions, pharmaceutical companies, biotechnology firms, and diagnostic laboratories.

What Is NGS Sample Preparation?

NGS sample preparation involves converting DNA or RNA samples into sequencing-ready libraries through a series of carefully controlled processes such as extraction, fragmentation, library preparation, target enrichment, and quality control.

The quality of sample preparation directly influences sequencing accuracy, sensitivity, reproducibility, and downstream data analysis, making it a vital component of every sequencing workflow.

As genomic applications expand into clinical diagnostics and personalized medicine, laboratories are increasingly investing in automated, standardized, and high-throughput sample preparation technologies.

Key Factors Driving Market Growth

Continuous Advancements in NGS Platforms

Modern sequencing instruments now offer significantly higher throughput, faster turnaround times, and improved accuracy. These advances are increasing demand for compatible sample preparation kits, reagents, automation systems, and quality control solutions capable of handling large sequencing volumes efficiently.

Declining Cost of Genome Sequencing

The dramatic reduction in sequencing costs has made NGS more accessible across healthcare, research, agriculture, and biotechnology sectors. As sequencing becomes routine, laboratories require scalable sample preparation workflows to maximize operational efficiency while maintaining high-quality results.

Growing Role of NGS in Clinical Diagnostics

NGS is increasingly being used in:

• Oncology diagnostics
• Rare disease identification
• Infectious disease detection
• Prenatal screening
• Carrier screening
• Pharmacogenomics

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=69735098

This expanding clinical adoption is driving demand for standardized and regulatory-compliant sample preparation technologies.

Increasing Use of NGS as an Alternative to PCR

Many laboratories are replacing traditional PCR-based testing with NGS because it enables comprehensive genomic analysis, multiplex testing, and detection of multiple genetic variants in a single assay. This shift continues to accelerate investments in advanced sample preparation platforms.

Improved Genotyping and Workflow Efficiency

Automation, microfluidics, and optimized library preparation protocols are significantly reducing manual labor, minimizing errors, and improving reproducibility, making NGS workflows faster and more cost-effective.

Market Challenges

Despite strong growth prospects, several factors may limit market expansion.

These include:

• Availability of alternative molecular technologies
• Limited sequencing expertise in smaller laboratories
• High initial investment requirements
• Complex workflow validation
• Bioinformatics integration challenges
• Variability in laboratory infrastructure

However, ongoing automation and standardized workflows are expected to address many of these challenges over the coming years.

DNA Segment Leads the Market

Based on sample type, the market is segmented into:

• DNA
• RNA

The DNA segment accounted for the largest market share in 2022.

Its leadership is primarily driven by:

• Rising global cancer incidence
• Expanding genomic research
• Increasing demand for hereditary disease testing
• Growth of precision oncology
• Higher investments in DNA sequencing research

DNA sequencing remains the foundation for many diagnostic and research applications, supporting sustained demand for DNA sample preparation products.

DNA Fragmentation & Library Preparation Emerges as the Fastest-Growing Workflow

By workflow, the market includes:

• DNA Fragmentation & Library Preparation
• Target Enrichment
• Quality Control

Among these, DNA fragmentation and library preparation represented the fastest-growing workflow segment in 2022.

Growth is being fueled by:

• Continuous protocol improvements
• Availability of innovative library preparation kits
• Automation technologies
• Reduced preparation time
• Higher sequencing accuracy
• Increased laboratory throughput

Library preparation continues to be one of the most innovation-driven segments within the NGS ecosystem.

Request for Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=69735098

Asia Pacific: The Fastest-Growing Regional Market

While North America continues to lead global adoption, the Asia Pacific region is projected to register the highest CAGR during the forecast period.

Several factors are driving this regional expansion:

• Increasing government funding for genomics
• Rising healthcare investments
• Growing biotechnology industry
• Expanding precision medicine initiatives
• Greater adoption of NGS diagnostics
• Rapid advances in genomic data analysis
• Increasing academic and clinical research collaborations

Countries including China, Japan, South Korea, India, and Singapore continue investing heavily in genomic infrastructure, creating significant market opportunities.

Competitive Landscape

The NGS sample preparation market remains highly consolidated, with leading companies focusing on:

• Product innovation
• Automated sample preparation systems
• Strategic partnerships
• Portfolio expansion
• Geographic expansion
• Acquisitions
• Clinical workflow optimization

Manufacturers are increasingly developing integrated solutions that combine reagents, consumables, instruments, automation, and software to streamline laboratory operations.

Major Companies Operating in the NGS Sample Preparation Market

Key industry participants include:

• Illumina, Inc. (US)
• Thermo Fisher Scientific Inc. (US)
• PerkinElmer Inc. (US)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Agilent Technologies, Inc. (US)
• Danaher (US)
• Becton, Dickinson and Company (US)
• Merck KGaA (Germany)
• QIAGEN (Germany)
• Bio-Rad Laboratories, Inc. (US)
• Promega Corporation (US)
• Eurofins Scientific (Luxembourg)
• BGI (China)
• 10x Genomics (US)
• Sysmex Corporation (Japan)
• Psomagen (US)
• Zymo Research Corporation (US)
• Takara Bio Inc. (Japan)
• Novogene Co., Ltd. (China)
• New England Biolabs (US)
• Tecan Trading AG (Switzerland)
• Oxford Nanopore Technologies PLC (UK)
• PacBio (US)
• MedGenome (India)
• Swift Biosciences Inc. (US)

These companies continue investing in automation, sequencing chemistry, AI-enabled workflow optimization, and integrated genomics platforms to strengthen their competitive positions.

Emerging Trends Shaping the Market

Several technological innovations are expected to redefine NGS sample preparation over the coming years.

Key trends include:

• Automated library preparation platforms
• AI-assisted workflow optimization
• Microfluidic sample processing
• High-throughput laboratory automation
• Single-cell sequencing workflows
• Multi-omics integration
• Cloud-connected laboratory management
• Precision oncology applications
• Liquid biopsy sample preparation
• Clinical-grade sequencing workflows

These innovations are improving reproducibility, scalability, and operational efficiency across both research and clinical laboratories.

Future Outlook

As genomics continues to influence precision medicine, drug discovery, infectious disease surveillance, and population health initiatives, sample preparation will remain one of the most strategically important components of the sequencing workflow.

Growing adoption of personalized medicine, declining sequencing costs, and increasing investments in genomic infrastructure are expected to sustain double-digit market growth over the coming years.

Organizations that prioritize workflow automation, standardized protocols, and integrated sample preparation technologies will be best positioned to capitalize on emerging opportunities across clinical diagnostics and life sciences research.

Conclusion

The global NGS Sample Preparation Market is entering a phase of rapid expansion, driven by technological innovation, increasing genomic research, broader clinical adoption, and automation of laboratory workflows. With the market projected to reach USD 4.0 billion by 2028, companies that deliver efficient, scalable, and high-quality sample preparation solutions will play a pivotal role in advancing the next generation of genomic medicine.

Get Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=69735098